Clinical Trial Update: Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. [Phase 2]

View source ↗

Summary

A Phase 2 investigational trial evaluating XC001 delivered via cardiac catheter in subjects with chronic angina is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease

Drugs mentioned

• XC001

Snippet

Sponsor: XyloCor Therapeutics, Inc. | Conditions: Refractory Angina, Coronary Artery Disease | Phase 2 | Status: RECRUITING